Royal dsm-firmenich, a global purpose-led science-based company, today announces a halt to Rovimix® Vitamin A production in Sisseln, Switzerland, for at least 2 months commencing January 2, 2023. Rovimix® Vitamin E-50 production will be significantly impacted as well due to its common upstream infrastructure.
At the start of the month November, dsm-firmenich communicated to clients the necessity to enact price increases for its high-quality vitamins to justify continuation of production in Europe in the current challenging cost environment. With higher energy costs foreseen this winter, dsm-firmenich has decided to halt Rovimix® Vitamin A production in Sisseln, Switzerland, which also impacts Rovimix® Vitamin E-50 production.
Existing contractual commitments will be honored and allocation procedures have been activated across the global production network to enact this in an orderly manner.
dsm-firmenich is committed to sustainable production of the highest quality feed additives, including the longstanding Rovimix® product range produced in Sisseln, Switzerland, provided that aligns with our aim to generate sustainable profitable growth.
Royal dsm-firmenich is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. dsm-firmenich’s purpose is to create brighter lives for all. dsm-firmenich’s products and solutions address some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. dsm-firmenich and its associated companies employ approximately 23,000 people around the world and deliver annual net sales of about €10 billion. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at https://www.dsm.com/.
21 November 2022
We detected that you are visitng this page from United States. Therefore we are redirecting you to the localized version.